NCT07311746 2025-12-31Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic LeukemiaM.D. Anderson Cancer CenterPhase 1/2 Not yet recruiting36 enrolled